This request seems a bit unusual, so we need to confirm that you’re human. Please press and hold the button until it turns completely green. Thank you for your cooperation!
Press and hold the button
If you believe this is an error, please contact our support team.
192.64.82.12 : 4d102073-422c-4065-98b9-5ce02196
Graphical abstract. Credit: Journal of Clinical Investigation (2024). DOI: 10.1172/JCI175447 A cellular link between obesity and atrial fibrillation—a heart condition that afflicts over 33 million people worldwide—presents a promising target
Bivalirudin is a safer and more effective anticoagulant than heparin for treating patients with the most serious type of heart attacks who undergo urgent percutaneous coronary intervention (PCI), and can
Just a moment… Enable JavaScript and cookies to continue This request seems a bit unusual, so we need to confirm that you’re human. Please press and hold the button until
